Skip to main content

Pancreatic Exocrine Function

  • Chapter
  • First Online:
Functional Dyspepsia

Abstract

Disorders of digestive tract functions, secretion, digestion, propagation, absorption, and metabolism, can easily lead to abdominal symptoms of meal-related diseases such as functional dyspepsia (FD). Pancreatic exocrine function also exerts an important role in digestion and absorption after meal. Therefore, pancreatic exocrine must be a significant function associated with the pathogenesis of FD as well as acid secretion and gastroduodenal motility. However, it is unclear which dysfunction or organ is an origin of abdominal symptoms of FD, because symptoms felt at the epigastrium are complicatedly caused by dysfunction of both the gastroduodenum and the adjacent organ (e.g., pancreas). In addition, it is known that a mismatch in the perception site and expression between the general epigastric symptoms and FD-specific symptoms often appears in most FD patients. This issue may cause poor understandings of the accurate pathogenesis of FD.

In this chapter, first of all, we introduce what kind of upper abdominal symptoms general Japanese subjects felt and where they felt FD-like symptoms using a questionnaire with an illustration divided into eight parts of the abdomen including the sternum, and then give the information about roles of pancreatic exocrine function and usual nutrition in the pathogenesis of FD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal Disorders. Gastroenterology. 2016;150:1380–92.

    Article  PubMed  Google Scholar 

  2. Kaji M, Fujiwara Y, Shiba M, Kohata Y, Yamagami H, Tanigawa T, et al. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol. 2010;25:1151–6.

    Article  PubMed  Google Scholar 

  3. Tack J, Carbone F, Holvoet L, Vanheel H, Vanuytsel T, Vandenberghe A. The use of pictograms improves symptom evaluation by patients with functional dyspepsia. Aliment Pharmacol Ther. 2014;40:523–30.

    PubMed  CAS  Google Scholar 

  4. Fujikawa Y, Tominaga K, Tanaka F, Kamata N, Yamagami H, Tanigawa T, et al. Postprandial symptoms felt at the lower part of the epigastrium and a possible association of pancreatic exocrine dysfunction with the pathogenesis of functional dyspepsia. Intern Med. 2017;56:1629–35.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wilmer A, Van Cutsem E, Andrioli A, Tack J, Coremans G, Janssens J. Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying. Gut. 1998;42:235–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Iwakiri R, Tominaga K, Furuta K, Inamori M, Furuta T, Masuyama H, et al. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan. Aliment Pharmacol Ther. 2013;38:729–40.

    Article  CAS  PubMed  Google Scholar 

  7. Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia: 100 mg t.i.d. is an optimal dosage. Neurogastroenterol Motil. 2010;22:618–e173.

    Article  CAS  PubMed  Google Scholar 

  8. Pandol SJ. The exocrine pancreas. San Rafael, CA: Morgan & Claypool Life Sciences; 2010.

    Google Scholar 

  9. Kuhn RJ, Gelrud A, Munck A, Caras S. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency. Adv Ther. 2010;27:895–916.

    Article  CAS  PubMed  Google Scholar 

  10. Miwa H, Kusano M, Arisawa T, Oshima T, Kato M, Joh T, et al. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol. 2015;50:125–39.

    Article  CAS  PubMed  Google Scholar 

  11. Detlefsen S, Sipos B, Feyerabend B, Klöppel G. Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch. 2005;447:800–5.

    Article  PubMed  Google Scholar 

  12. Torigoe T, Ito K, Yamamoto A, Kanki A, Yasokawa K, Tamada T, et al. Age-related change of the secretory flow of pancreatic juice in the main pancreatic duct: evaluation with cine-dynamic MRCP using spatially selective inversion recovery pulse. Am J Roentgenol. 2014;202:1022–6.

    Article  Google Scholar 

  13. Yasokawa K, Ito K, Tamada T, Yamamoto A, Hayashida M, Tanimoto D, et al. Noninvasive investigation of exocrine pancreatic function: Feasibility of cine dynamic MRCP with a spatially selective inversion-recovery pulse. J Magn Reson Imaging. 2015;42:1266–71.

    Article  PubMed  Google Scholar 

  14. Rothenbacher D, Löw M, Hardt PD, Klör HU, Ziegler H, Brenner H. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study. Scand J Gastroenterol. 2005;40:697–704.

    Article  PubMed  Google Scholar 

  15. Herzig KH, Purhonen AK, Räsänen KM, Idziak J, Juvonen P, Phillps R, et al. Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitus. BMC Geriatr. 2011;11:4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Tominaga K, Fujikawa Y, Tsumoto C, Kadouchi K, Tanaka F, Kamata N, et al. Disorder of autonomic nervous system and its vulnerability to external stimulation in functional dyspepsia. J Clin Biochem Nutr. 2016;58:161–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Pilichiewicz AN, Feltrin KL, Horowitz M, Holtmann G, Wishart JM, Jones KL, et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol. 2008;103:2613–23.

    Article  CAS  PubMed  Google Scholar 

  18. Tominaga K, Tsumoto C, Ataka S, Mizuno K, Takahashi K, Yamagami H, et al. Regional brain disorders of serotonin neurotransmission are associated with functional dyspepsia. Life Sci. 2015;137:150–7.

    Article  CAS  PubMed  Google Scholar 

  19. Levine ME, Koch SY, Koch KL. Lipase supplementation before a high-fat meal reduces perceptions of fullness in healthy subjects. Gut Liver. 2015;9:464–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshiko Fujikawa .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fujikawa, Y., Tominaga, K. (2018). Pancreatic Exocrine Function. In: Tominaga, K., Kusunoki, H. (eds) Functional Dyspepsia. Springer, Singapore. https://doi.org/10.1007/978-981-13-1074-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-1074-4_16

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-1073-7

  • Online ISBN: 978-981-13-1074-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics